Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease

US Patent 8865701 · Granted Oct 21, 2014

Estimated economic value: $128,538,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinoline compounds and compositions for inhibiting EZH22025
Kinase inhibitors2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Antiplatelet drugs and uses thereof2025
Salt form and crystal form of mutant IDH1 inhibitor and preparation method there2025
MLL1 inhibitors and anti-cancer agents2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
Tetradentate and octahedral metal complexes containing naphthyridinocarbazole an2025
Color tunable hybrid led-OLED illumination devices2025
Tetradentate metal complexes with carbon group bridging ligands2025
Silicon-containing compounds for lubricants2025